Common pain reliever can improve survival in head and neck cancer

(University of California - San Francisco) Regular use of a common type of medication, such as aspirin and ibuprofen, significantly improves survival for a third or more patients with head and neck cancer, a new study led by UC San Francisco has found.

https://www.eurekalert.org/pub_releases/2019-01/uoc--cpr012319.php

Source: EurekAlert! - Cancer - January 25, 2019 Category: Cancer & Oncology Source Type: news